Estrella Immunopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Estrella Immunopharma (ESLA).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$8Upside to Avg. PT+2039.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Feb 9, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$8
Jan 28, 2026	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$16→$8
Nov 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Aug 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jun 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
May 29, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Feb 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Feb 18, 2025	D. Boral Capital	Jason Kolbert	Initiate	Buy	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and lowers the price target from $16 to $8.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.

Benzinga Newsdesk

Estrella Immunopharma Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Estrella Immunopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

People Also Watch

People Also Watch

Estrella Immunopharma Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Estrella Immunopharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PROD. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

People Also Watch

People Also Watch

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target